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Reflux of Endoplasmic Reticulum proteins to the
cytosol inactivates tumor suppressors
Daria Sicari1,2,† , Federica G Centonze1,2,‡, Raphael Pineau1,2,‡, Pierre-Jean Le Reste1,2,3,
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Abstract
In the past decades, many studies reported the presence of endo-
plasmic reticulum (ER)-resident proteins in the cytosol. However,
the mechanisms by which these proteins relocate and whether
they exert cytosolic functions remain unknown. We find that a
subset of ER luminal proteins accumulates in the cytosol of
glioblastoma cells isolated from mouse and human tumors. In
cultured cells, ER protein reflux to the cytosol occurs upon ER
proteostasis perturbation. Using the ER luminal protein anterior
gradient 2 (AGR2) as a proof of concept, we tested whether the
refluxed proteins gain new functions in the cytosol. We find that
refluxed, cytosolic AGR2 binds and inhibits the tumor suppressor
p53. These data suggest that ER reflux constitutes an ER surveil-
lance mechanism to relieve the ER from its contents upon stress,
providing a selective advantage to tumor cells through gain-
of-cytosolic functions—a phenomenon we name ER to Cytosol
Signaling (ERCYS).
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Introduction
The endoplasmic reticulum (ER) is the gateway to the secretory
pathway thus maintaining the communication between the cell’s
intracellular space and extracellular environment. In addition, the
ER is a sensing organelle that coordinates many stress signaling
pathways (Higa & Chevet, 2012; Alexia et al, 2013; Hetz et al,
2015). Secretory and transmembrane proteins translocate into the
ER through different translocation/membrane insertion molecular
machines including the Sec61 channel. The ER is crowded with
molecular chaperones and foldases that ensure these proteins’
productive folding followed by their export en-route to their final
destination (Rapoport, 2007). Diverse perturbations compromise the
folding and maturation of secretory proteins in the ER thereby caus-
ing ER stress. To ensure productive folding, cells have also evolved
various ER quality control (ERQC) systems allowing for further fold-
ing rounds (Adams et al, 2019) and their degradation in the cytosol
by a process termed ER-associated degradation (ERAD) (Travers
et al, 2000; Rutkowski et al, 2006; Vembar & Brodsky, 2008). In
addition to ERQC and ERAD, a pre-emptive quality control (pre-QC)
mechanism was also described that averts protein entry into the
secretory pathway under protein-folding stress resulting in their
proteasomal degradation in the cytosol (Kang et al, 2006). If these
quality control systems are overwhelmed, ER stress activates a
signaling pathway called the unfolded protein response (UPR) that
aims at restoring ER homeostasis. However, if the UPR adaptive
function fails, cell death programs are activated (Almanza et al,
2019). The UPR is transduced by three transmembrane proteins
(PERK, ATF6α and IRE1α) that sense and monitor the protein-
folding status of the ER through their luminal domains and transmit
signals to the rest of the cell through their cytosolic domain
(Almanza et al, 2019).
In the past three decades, a subset of ER-resident proteins was
reported to accumulate in the cytosol. This was observed in several
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human diseases including cancer and degenerative diseases (Turano
et al, 2002; Afshar et al, 2005; Tarr et al, 2010; Galligan & Petersen,
2012; Kanekura et al, 2015; Wiersma et al, 2015; Shim et al, 2018).
The localization of proteins identified as ER-resident to other cellu-
lar compartments has been extensively reported for instance for
members of the protein disulfide isomerase (PDI) family, for
GRP78/BiP or for calreticulin (Turano et al, 2002; Afshar et al, 2005;
Tarr et al, 2010; Galligan & Petersen, 2012; Wiersma et al, 2015;
Shim et al, 2018). Despite this recurring observation, the mecha-
nisms by which ER-resident proteins relocate in the cytosol and
the potential functions of those proteins in this compartment
remain unclear.
Recently, we showed that protein-folding stress causes ER-
resident proteins to be refluxed to the cytosol in the yeast Saccha-
romyces Cerevisiae (Igbaria et al, 2019). This mechanism requires
ER and cytosolic chaperones and co-chaperones but is independent
of ERAD and of protein degradation (Igbaria et al, 2019). Here, we
found that ER stress-mediated protein reflux is conserved in
mammalian cells and in cancer cells isolated from human and
murine tumors in which it aims at debulking the ER upon stress.
Moreover, we found that this process to be constitutively active in
tumor cells and lead to cytosolic gain-of-functions of the refluxed
protein as inhibitor of tumor suppressors, thereby exhibiting pro-
oncogenic features.
Results
ER-resident proteins are refluxed from the ER lumen to
the cytosol in cancer cells isolated from human and murine
GBM tumors
To study the role of ER protein reflux in tumors, we initially
focused on Glioblastoma multiforme (GBM) in which the unfolded
protein response (UPR) sustains tumor aggressiveness (Obacz
et al, 2017). Mouse GBM cells (GL261) were grafted orthotopically
in the brain of immunocompetent C57BL/6 mice and 30 days
post-injection, tumors were resected, dissociated, and isolated
tumor cells subjected to subcellular fractionation using previously
validated fractionation protocols (Holden & Horton, 2009). Immu-
noblot analysis of the digitonin fraction (enriched in cytosolic
proteins) from freshly isolated tumor cells was compared with
that of dissociated control tissue from the opposite hemisphere
of the brain (non-tumor). It revealed higher levels of select ER-
resident proteins in tumor than in the non-tumor cells’ cytosolic
fractions (Fig 1A-1E and Appendix Fig S1A and B). Several ER-
resident proteins (ERp29/PDIA9 and ERp57/PDIA3) were enriched
up to ∼ 70% in the cytosolic fraction compared with only ∼
10% enrichment in non-tumor controls. These results indicate that
tumor cells are more prone to exhibit reflux of ER proteins to the
cytosol than non-tumoral cells. To rule out the possibility that ER
stress in tumor cells may change the composition of the ER
membrane thereby sensitizing it to digitonin treatment (detergent),
we consequently used a digitonin-free subcellular protein fraction-
ation protocol (Lodish, 2000). Cells were disrupted using a 26-
gauge needle, and then, differential centrifugation was applied as
shown in Appendix Fig S1C. After analyzing the cytosolic frac-
tions, we observed results comparable to those obtained with the
digitonin-based protocol (Fig 1A and Appendix Fig S1D). We con-
firmed these findings in another GBM model, the human U87 cells
orthotopically implanted in the brain of NSG mice (Appendix Fig
S1E). These two different protocols further strengthen the notion
that ER proteins do exit the ER to reach the cytosol more actively
in tumor cells.
We next asked whether this phenomenon is also observed in
human GBM samples freshly isolated from patients at surgery
(Table S1). We tested the subcellular localization of ER-resident
proteins in freshly isolated human tumor cells. Tumor tissues were
dissociated, and digitonin fractions tested for the presence of ER
luminal proteins using immunoblotting. In the majority of tumors
(80% of the tested tumors), ∼ 50% of the ER proteins evaluated
were detected in the digitonin fraction including ERDJ3/DNAJB11 in
its N-glycosylated state (Fig 1F-G and Appendix Fig S1F). Moreover,
individual tumors exhibited heterogenous refluxed protein patterns,
which might reflect inter-tumor heterogeneity (Fig 1F and G). In
both GBM tumors (human- or murine-derived, N-linked-glycopro-
teins (such as ERDJ3/DNAJB11) were found in the digitonin fraction
thus indicating that the refluxed proteins had been translocated into
the ER and modified by N-Linked glycosylation, before being
refluxed to the cytosol (Appendix Fig S1G-H).
These data indicate that in GBM, ER protein reflux might be
selectively regulated by different factors such as tumor heterogene-
ity, genetic background, or activation status of UPR. These findings
will certainly stimulate others to replicate and extend these data in
other tumor models.
ER stress mediates ER-resident proteins reflux from the ER
to the cytosol
We next sought to identify factors regulating ER-to-cytosol protein
reflux. Recently, we reported that ER luminal proteins were refluxed
to the cytosol upon ER stress in the yeast S. cerevisiae (Igbaria et al,
2019; Lajoie & Snapp, 2020) in a chaperone-mediated process
(Igbaria et al, 2019). We tested whether ER stress/UPR activation—
two factors that showed a correlation with protein reflux in S. cere-
visiae—would also cause ER protein reflux in mammalian cells. As
such we monitored the localization of an engineered ER-targeted
super-folder GFP (ER-sfGFP) using confocal microscopy, to follow
the fate of ER-sfGFP in living cells. The cells were also transfected
with the cytosolically localized mCherry used as a cytosolic marker.
Notably, cells treated with Tunicamycin (Tm), which perturbs
protein folding by inhibiting N-linked glycosylation, Thapsigargin
(Tg) which inhibits the sarco-endoplasmic reticulum Ca2 + ATPase
or Brefeldin A (BFA) that prevents protein transport from the ER to
the Golgi apparatus, showed enhanced colocalization of ER-sfGFP
with the cytosolic mCherry. The cytosolic colocalization of ER-
sfGFP/mCherry reached a maximum after 24hrs of treatment (Fig 2
A and Appendix Fig S2A). To confirm that the ER-resident proteins
found in the cytosol after ER stress originated from the ER lumen,
we engineered an ER-targeted photoactivatable fluorescent protein
(FP) called mEOS3.2 by adding an ER signal peptide and a KDEL
ER-retention sequence that discriminates newly synthesized
proteins from the pre-existing pool. Indeed, UV exposure shifts the
excitation maxima of the mEOS3.2 from 488nm to 573nm, allowing
detection of proteins synthesized before a UV pulse exposure
(Appendix Fig S2B). Notably, after a UV pulse and Tm or DMSO
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treatments for 24 h, the mEOS3.2573 pool was mainly localized in
the ER of the DMSO treated cells, but cells treated with Tm or BFA
showed a significant fraction of mEOS3.2573 localized in the cytosol
(Appendix Fig S2B). These results indicated that during stress pre-
existing and ER localized proteins are refluxed to the cytosol where
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Figure 1. ER proteins are rerouted to the cytosol in human and mouse Glioblastoma (GBM) tumors.
A Representative Western blots after subcellular protein fractionation experiment in isolated murine-derived non-tumor (NT) and GBM tumor (T) tissues.
B Total levels of the ER-luminal proteins tested from the cell lysate derived from tissues used in (A).
C–E Quantification of the protein levels of ER luminal proteins in the cytosolic fraction as shown in (A). n = 5 biological replicates and the horizontal line represent the
sample mean. Differences were analyzed by Unpaired Student’s t-test using Prism 9 (GraphPad), except when otherwise indicated. P-values < 0.05 were considered
significant).
F, G Human-derived GBM tumors were processed as in (A). Representative Western blot was performed (F), and the percentage of ER-luminal protein cytosolic
localization (G) were quantified. Data are the average from six different tumors. N = 6 Bars and error bars indicate mean
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We next tested whether endogenous ER-resident proteins were
also refluxed to the cytosol in cultured cells that were exposed to
various ER stress inducers. Subcellular protein fractionation using
minimal concentration of digitonin that results in proper separation
of the different subcellular fractions was carried out in cells
subjected to ER stress induced by Tm or Tg. This was followed by
an analysis of the localization of different endogenous ER-resident
proteins including the soluble ERp29, PRDX4, PDIA3, and the inte-
gral protein calnexin (CANX). We found that soluble ER luminal
proteins were enriched in the digitonin fraction up to 50-55% (Fig 2
B and D) but not calnexin, thus indicating that ER reflux could be
exclusive for soluble proteins. We then compared those results to
those obtained from the detergent-free protocol (Lodish, 2000) using
differential centrifugation, to rule out the possibility that ER stress
inducers may alter the ER membrane properties toward digitonin.
As shown in Fig 2C and E, we observed results similar to those
obtained with the digitonin-based protocol (Fig 2B and D). We
further investigated this by examining the integrity of the ER
membrane in those cells. We obtained pellets post-digitonin fraction
and after the 100,000xg centrifugation and treated them with protei-
nase K in the absence or presence of TritonX-100. We reasoned that
if the ER membrane is damaged/ruptured due to digitonin or dif-
ferential centrifugation protocols, ER luminal proteins should be
sensitive to proteinase-K-mediated proteolysis. As shown in
Appendix Fig S2C and D, while proteinase K was active toward the
cytosolic portion of Calnexin, the ER luminal proteins were
protected from proteinase-K in the absence of TritonX-100 in post-
digitonin pellet. Similar results were also observed in the 100,000 g
pellet (Appendix Fig S2C and D). Moreover, if the ER membrane is
damaged or ruptured due to ER stress, we could expect that it
should be permeable to small metabolite such as Glutathione. As
such using a version of the redox sensitive eroGFP that is attached
to the ER membrane with the eroGFP facing the luminal side, we
found that the redox state of eroGFP remained oxidized even during
ER stress (Appendix Fig S2E). Those data indicate that during ER
protein reflux, the ER membrane is not significantly damaged
neither after digitonin treatment nor following differential centrifu-
gation protocols used in our study.
Next, we sought to systematically characterize the spectrum of
proteins from the secretory pathway refluxed from the ER. To this
end, we enriched N-glycosylated proteins from the digitonin fraction
extracted from HEK293T cells treated with Tg (Appendix Fig S2F).
The purified material was subjected to mass spectrometry analysis.
We focused on soluble glycoproteins that were enriched in the
cytosolic fraction after Tg treatment compared with control. We
identified 26 different soluble secretory N-glycoproteins present in
the cytosol (Table S2). Gene Ontology-based analysis showed that
these proteins mostly emanated from both ER and lysosomal
compartments. Moreover, 23 out of these 26 proteins were part of a
unique functional network (Fig 2F and Appendix Table S2), thus
suggesting functional implications to this observation. We also
performed a similar analysis on digitonin fractions from GBM tumor
cells (isolated from patients) and compared them with our previous
analysis of Tg treated HEK293T fractions. Interestingly, about 60%
of hits were enriched in both fractionation approaches (Fig 2G and
Appendix Table S2). This observation led us to hypothesize that
during ER stress the reflux of ER proteins to the cytosol may play an
important role to decrease the protein load within the ER in order to
regain homeostasis. ER protein reflux was also observed in other
cancer cell lines such as GL261, U87, and A549 (lung adenocarci-
noma) (Fig 3A–H and Appendix Fig S3A–F) using the two aforemen-
tioned subcellular protein fractionation protocols. Next, analysis of
immunogold-labeled electron microscopy images unveiled that
PDIA3 distributed to non-ER locations in cells treated with ER stres-
sors compared with DMSO treated cells (Fig 4A–C). It is worth to
note that in cancer cells the amount of ER proteins refluxed to the
cytosol was higher than in non-cancer cells (Appendix Fig S3G).
These data indicate that upon ER stress, ER luminal proteins
(and ER-targeted sfGFP/mEOS3.2) are refluxed to the cytosol. Fluo-
rescence microscopy with ER-sfGFP and ER-mEOS3.2 in HEK293T
cells (Fig 2A, Appendix Fig S2A and Fig 4) confirmed the results
obtained using cell fractionation and serve as alternative detergent-
free methods to monitor reflux from the ER. Moreover, the ER-mEOS3.2
experiment showed that ER protein reflux occurred for proteins
that already resided in the ER rather than as a result of the
pre-emptive quality control mechanism (Kang et al, 2006).
ER stress-mediated reflux as an ER to CYtosol Signaling (ERCYS)
pathway to inhibit tumor suppressors
Thus far, we have shown that ER protein reflux is constitutive in
some cancer cells as is the activation of the UPR and we thus
hypothesized that, as the UPR, it may play an adaptive and pro-
oncogenic function contributing to cancer cells increased fitness. To
◀ Figure 2. Pre-existing, ER-targeted mEOS3.2 and ER endogenous proteins reflux to the cytosol during ER stress.
A Left: Representative images of cells were transfected with super-folder GFP (sfGFP) treated with 250 ng/ml Tunicamycin (Tm), 50 nM Thapsigargin (Tg), and 250
ng/ml Brefeldin-A (BFA) for 24 h. Right: Quantification of the microscopy images of cells expressing ER-targeted sfGFP and the cytosolically localized mCherry. Data
values are the mean  SD of technical replicates (n = 10) from three independent experiments (****P < 0.0001). One-way ANOVA was applied for the statistical
analysis through the GraphPad Prism 9 software. Scale bar 15 μm.
B, C Subcellular protein fractionation of several ER-resident proteins in HEK293T cells treated with the indicated concentrations of Tm or Tg for 16 h using Digitonin
(NP40 represents the membrane fraction extracted with NP40 Cell Lysis Buffer) (B) or differential centrifugation (C) protocols, representative Western blots are
showed.
D, E Quantification of the subcellular protein fractionation of several ER endogenous proteins in HEK293T cells treated with different concentrations of Tm and Tg for
16 h from panels (B and C), respectively. Biological triplicates, mean  SD calculated using Prism 9 (GraphPad).
F Mass spec analysis of soluble ER-targeted glycoproteins in HEK293T cells treated with Tg and analyzed as described in materials and methods. Biological triplicates
and data analyses were carried using Cytoscape v3.8.0 for network representation (PMID: 14597658) with the Cytoscape Stringapp for enrichments (PMID:
30450911). Statistics were done using the default settings of the Cytoscape app.
G Mass spectrometry analysis of cytosolically located soluble ER glycoproteins in HEK293T cells treated with Tg compared with that found in human GBM tumor
cells-derived cytosols.
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investigate possible adaptive mechanisms of the reflux process, we
evaluated the nature of refluxed proteins in A549 cells subjected to
ER stress (Fig 3, Appendix Fig S3A–F and Fig 5A). We focused on
Anterior GRadient 2 (AGR2, PDIA17) that was highly enriched in
the digitonin fractions upon ER stress (Fig 5A and Appendix Fig
S3A–C). AGR2 is a PDI family member thought to catalyze protein
folding through thiol-disulfide based reactions (Chevet et al, 2013).
In many studies, it has been shown to exert pro-oncogenic functions
through yet ill-defined mechanisms. For instance, AGR2 was shown
to interact with and to inhibit the activity of the p53 tumor suppres-
sor (Pohler et al, 2004). Here, we propose a model in which ER
stress in cancer cells may cause constitutive AGR2 reflux to the
cytosol, where AGR2 might in turn gain new functions to interact
and inhibit p53. To test this hypothesis, co-immunoprecipitation
experiments showed that upon stress AGR2 was translocated to the
cytosol and interacted with wild-type (wt) p53 in A549 cells treated
with Tm, Tg, or BFA (Fig 5B). This was shown by measuring wt
p53 transcriptional and p21 protein expression levels (a downstream
target of p53 signaling). Tm, Tg, or BFA treatment reduced p21
protein levels, as well as wt p53 phosphorylation and transcriptional
activity as shown in cells transfected with a luciferase reporter
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Figure 3. ER protein reflux is constitutive in cancer cells.
A–C Subcellular protein fractionation of several ER-resident proteins in (A) GL261, (B) U87 and (C) A549 cells treated with the indicated concentrations of Tm or Tg using
Digitonin. (NP40 represents the membrane fraction extracted with NP40 Cell Lysis Buffer)
D–F Quantification of the subcellular protein fractionation of several ER endogenous proteins in GL261, U87, and A549 cells as in (A–C), respectively. Biological
triplicates, mean  SD calculated using Prism 9 (GraphPad).
G Subcellular protein fractionation of several ER-resident proteins in A549 cells treated with the indicated concentrations of Tm or Tg using differential centrifugation
protocol.
H Quantification of the subcellular protein fractionation of several ER endogenous proteins in A549 as in (G). Biological triplicates, mean  SD calculated using Prism
9 (GraphPad).
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A549 cells showed increased p53 phosphorylation and p21 protein
levels under ER stress conditions compared with control cells (Fig 5
D and E). This confirmed that AGR2 is involved in the inhibition of
wt p53 activity under ER stress. To further document that the
observed inhibition of wt p53 is linked to the presence of refluxed
AGR2, we engineered two nanobodies to specifically target AGR2
(either in the ER or in the cytosol) (Fig 5F). Notably, both AGR2
nanobodies showed minimal decrease in p21 protein levels and p53
phosphorylation compared to cells transfected with control
nanobodies (Fig 5E). Finally, to shed the light on the physiological
function of such inhibition on cancer cells fitness, we performed a
sulforhodamine-B assay in cells treated with ER stressors and etopo-
side for different periods of time. We found that sub-toxic concen-














































Figure 4. PDI proteins are redistributed to the cytosol during ER stress.
A, B Representative transmission electron microscopy images of the gold particles distribution (after immunogold labeling with PDIA3 antibodies) in A549 cells treated
with DMSO or Tm. In the inserts, gold particles in the ER were surrounded by red circles and those in the rest of the cytoplasm by blue circles. (Scale bar 500 nm).
n represents the nucleus, and m represents the mitochondria.
C Violin plots of the gold particles distribution from the electron microscopy experiment (immunogold labeling of PDIA3) as shown in (B, C). *P-value = 0.0486. n = 8
for DMSO and n = 8 for Tm. Thick horizontal lines represent mean  SD -lighter dashed lines. Differences were analyzed by Unpaired Student’s t-test using Prism
9 (GraphPad).
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etoposide while in the absence of AGR2 the toxicity was increased
after etoposide addition (Appendix Fig S3H and I).
These data showed that cytosolically localized AGR2 gains new
functions through interacting and inhibiting wt p53 activity. As
such, targeting cytosolic AGR2 in cancers could be used to
restore p53 pro-apoptotic transcriptional activity and sensitize them
to existing anti-cancer therapies. Alternatively, in pre-neoplastic
stages such as Barrett’s esophagus, in which AGR2 was first
described to inhibit p53 (Pohler et al, 2004), the targeting of cytoso-
lic AGR2 might prevent the inhibition of p53 tumor suppressor
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Figure 5. AGR2 reflux from the ER to the cytosol in A549 cells results in non-genetic inactivation of p53.
A Quantification of the subcellular protein fractionation of AGR2 in A549 cells treated with Tunicamycin (Tm), Thapsigargin (Tg), and Brefeldin-A (BFA) for different time
points as shown in Appendix Fig S3A–C. n = 3, biological replicates (mean  SD. Differences were analyzed using Prism 9 (GraphPad), except when otherwise
indicated.
B Immunoprecipitation of p53 and AGR2 in the digitonin fraction of A549 cells. A549 cells were treated with Tunicamycin (Tm 100 ng/ml), Thapsigargin (Tg 25 nM), and
Brefeldin A (BFA 0.1 and 0.25 nM). Endogenous p53 was immunoprecipitated from the cytoplasmic fraction (digitonin fraction) of A549 cells. Coprecipitated
endogenous AGR2 was detected by Western blot.
C A549 were treated with Etoposide (Eto) for 2 h to induce p53 pathway. Then, cells have been challenged with Tm, Tg, and BFA at the indicated concentrations for
16 h. Luciferase experiments were performed after 24 h of transfection. Graph shows the fold induction of p53 luciferase construct. Western blot experiments for
phospho-p53, pan-p53, p21, and HSP90 were performed as control. n = 3, biological replicates (mean  SD; Differences were analyzed by Unpaired Student’s t-test
using Prism 9 (GraphPad), except when otherwise indicated. *P < 0.05, ***P < 0.001.
D A549 were transfected with control siRNA (siC) and AGR2-tergetd siRNA (siAGR2). After 24 h, cells were transfected with p53-luciferase construct. Cells were then
treated as in (C), and luciferase experiments were performed. n = 4, biological replicates (mean  SD. Differences were analyzed by Unpaired Student’s t-test using
Prism 9 (GraphPad), except when otherwise indicated.
E Left: Western blot experiments for phospho-p53, pan-p53, and p21 in AGR2-silenced A549 cells exposed to ER stressors: 100 ng/ml Tunicamycin (Tm), 25 nM
Thapsigargin (Tg), and 0.25 nM Brefeldin A (BFA), in the presence and absence of etoposide. Right: Quantification of the Western blot. n = 3, biological replicates,
mean  SD.
F A549 were transfected with the indicated constructs of differently targeted nanobodies, cells were then treated with Tunicamycin (Tm 100 ng/ml and 250 ng/ml),
Thapsigargin (Tg 25 nM), and Brefeldin A (BFA 0.25 nM) for 16 h at the indicated concentration. Western blot experiments were performed, and HSP90 were used as
loading control. n = 3, biological replicates mean  SD of n = 3 independent experiments (***P < 0.001 and **P < 0.01). Differences were analyzed by Unpaired
Student’s t-test using Prism 9 (GraphPad), except when otherwise indicated.
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Discussion
The phenomenon described in this manuscript and relying on ER
stress-mediated protein reflux may act as an ER surveillance mecha-
nism that is evolutionary conserved from yeast to mammals to
achieve adaptive functions under stress conditions. This phenom-
enon causes ER-resident proteins to relocate to the cytosol in dif-
ferent cell lines and was found to be constitutively active in cancer
cell lines and in cells freshly isolated from human tumors or from
murine tumor models. Moreover, the data presented herein show
that this mechanism applies to a large spectrum of (glyco) proteins
from the secretory pathway and it is not directly dependent/related
to protein size.
ER-to-CYtosol-Signaling (ERCYS) may also play an important
physiological role. To date, several mechanisms were reported to
decrease ER protein load either through signaling mechanisms
including regulated IRE1-dependent decay (RIDD) of RNA, PERK-
mediated global protein translation attenuation or through clearance
mechanisms including pre-emptive quality control and ERAD
processes. However, here, we demonstrate that ERCYS can reduce
secretory protein load in the ER lumen by refluxing folded and
mature proteins to the cytosol during stress. Moreover, ERCYS-
mediated protein reflux into the cytosol is associated with selective
gain-of-function that is pivotal for cancer development and/or
progression. Indeed, this mechanism as illustrated by the cytosolic
gain-of-function acquired by AGR2, could represent a non-geneti-
cally mediated tumor suppression through an inhibitory interaction
with p53. As such, this could be one of many other mechanisms by
which refluxed ER proteins in tumor cells could influence existing
pro-apoptotic signaling pathways in the cytosol (Fig 6 and
Appendix Fig S3H and I).
Beyond AGR2, another protein found to be refluxed in our study
was previously shown to influence pro-apoptotic signaling in the
cytosol. Indeed, the UDP-Glucose-Glucosyl Transferase 1 (UGGT1)
was shown to redeploy to the cytosol during enterovirus A71
(EA71) infection to help viral RNA synthesis (Huang et al, 2017).
EA71 infection has been associated to ER stress induction (Jheng
et al, 2018) thus supporting the hypothesis that ERCYS is an ER
stress-dependent process. In addition, one of the UGGT1 interacting
proteins is the cytosolic scaffold protein DAB2IP (Hein et al, 2015).
DAB2IP negatively regulates various signaling pathway involved in
cancer progression (Bellazzo et al, 2017). Thus, UGGT1/DAB2IP
interaction might also represent another pro-oncogenic feature
of ERCYS.
In addition, we previously reported that ER stress-mediated
protein reflux is regulated by the ER-resident tail-anchored HSP40
co-chaperone Hlj1p (Igbaria et al, 2019). HLJ1-like HSP40s are
conserved in the human genome, and DNAJB12 (Type-II HSP40)
was characterized as an HLJ1-like HSP40 (Grove et al, 2011).
DNAJB12 and its homologue DNAJB14 have similar functionality as
Figure 6. Proposed ERCYS’ working model.
Cartoon showing our working model, in cancer cells, basal ER stress promotes reflux of some PDI and PDI-L proteins including AGR2 to the cytosol. In the cytosol, AGR2 is
able to bind and inhibit p53 function.
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Hlj1p, and they are both required for proteasomal degradation of
misfolded membrane proteins (Youker et al, 2004; Yamamoto et al,
2010; Grove et al, 2011). In addition, both DNAJB12 and DNAJB14
facilitate the penetration of non-enveloped viruses from the ER to
the cytosol by forming a cytosolic chaperone complex with the
cytosolic heat shock protein 70, HSC70 (Goodwin et al, 2011;
Walczak et al, 2014). Because ER protein reflux and the penetration
of viruses from the ER to the cytosol behave similarly, we speculate
that viruses hijacked an evolutionary conserved machinery—ER
protein reflux—to penetrate to the cytosol.
This evidence supports the idea that ER-resident proteins
might change their localization in such specific conditions, as ER
stress or virus infection, to acquire novel features associated with
their new location. Further studies on the role(s) of the cytosoli-
cally localized AGR2 and other PDI-like proteins as well as on
the precise nature of the refluxed ER proteins will certainly
impact on the understanding ER stress-mediated diseases includ-
ing cancer and will open new areas for biological exploration and
therapeutic strategies.
Materials and Methods
Cell culture and transfection
Human HEK293T, A549, MCF7, U87, and mouse GL261 cell lines
cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% FBS and 1% antibiotics at 37°C
in a 5% CO2 incubator. PG13-luc (WT p53 binding sites) was a
gift from Bert Vogelstein (Addgene plasmid # 16442; http://n2t.ne
t/addgene:16442; RRID: Addgene_16442). Cells were transfected
with Lipofectamine LTX and plus reagent or Lipofectamine 2000
(Thermo Fisher Scientific) according to the manufacturer’s proto-
cols. Small-interfering RNAs (siRNA) were obtained from Ambion
Each siRNA (25 nM) was transfected by reverse transfection using
Lipofectamine RNAiMAX (Invitrogen). Thapsigargin (Tg), Etopo-
side (Eto), and Brefeldin A (BFA) were obtained from Sigma-
Aldrich (St. Louis, MO, USA). Tunicamycin (Tm) was purchased
from Calbiochem.
Immunoblot and immunoprecipitation
Whole cell extracts were prepared using RIPA buffer (25 mM Tris–-
HCl pH 7.5, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate,
and 0.1% SDS). Primary antibodies were incubated overnight at
4°C. Secondary antibodies were incubated 1h at RT (1:7000), and
the antibodies used in this work are listed in Table 1. For the
immunoprecipitation analysis, cells were lysed in Co-IP buffer
(50 mM Tris–Hcl pH 8, 150 mM NaCl, 0.5% TritonX100, and 1 mM
EDTA), incubated 30’ on ice and then incubated 16 h at 4°C with
the anti-AGR2 or anti-p53 antibodies (1 µg Ab/1,000 µg protein).
After this, Dynabeads protein G/A (Life Technologies) were first
washed with CoIP lysis buffer, then mixed with the protein/Ab
mixture, incubated at 4°C for 3 h with gentle rotation and washed
with Co-IP buffer. Finally, the beads were eluted with 50 µl of
Laemmli sample buffer, heated at 100°C for 5 min, and loaded
to SDS–PAGE. For the immunoblotting, anti-AGR2 or anti-p53
antibodies were used.
Tumor isolation
All human samples used for the analyses shown in this manuscript
were provided by the Centre de Ressources Biologiques (CRB) Sante
of Rennes (BB-0033-0005). Informed consent was obtained in accor-
dance with the French legislation under the auspices of French
National authorities. Mouse and human brain samples were
collected and mechanically dissociated using gentleMACS dissocia-
tion following the manufacturer’s instructions (Miltenyi Biotec,
Paris, France). Freshly isolated tumor tissues were suspended in
5ml DMEM immediately after being surgically removed and placed
in a petri dish. Tumor and non-tumor tissues were cut to small
pieces of 1–2 mm3 using a sterile scalpel and then transferred to C-
tube and tightly closed. Then, we used the mechanical dissociation
program A.01 for C-tubes (the most gentle program to homogenize
tissues). The resulting homogenate was then directly decanted into
40 μm cell strainer into 50ml tube. Cells were then pelleted at 100
RCF for 5 min washed and re-pelleted for another 5 min before
being subjected to 25 μg/ml digitonin as shown below in the subcel-
lular protein fractionation protocol.
Differential centrifugation
Cells were washed with PBS and trypsinized for 5min, pellets were
collected at 300 x g and washed again with ice cold PBS. Cells were
suspended in homogenizing buffer (20 mM HEPES pH7.4, 10 mM
KCl, 2 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and
protease inhibitor cocktail) and then passed 15 times through a















pan-p53 (DO-1) (Mouse) SantaCruz/sc-126
pan-p53 (Valentino) (Rabbit) Gift from LNCIB (Girardini et al, 2011)
phospho-p53 (Ser15) Cell signaling #9284
p21 Waf1/Cip1 (12D1) Cell signaling #2947
Calnexin (CANX) Gift from JJM Bergeron (McGill, Canada)
(Ou et al, 1993)
GADPH (G-9) SantaCruz/sc-365062
HSP90 (4F10) SantaCruz/sc- 69703
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26-gauge needle (1 ml syringe). After incubation for 20 min on ice,
the lysates were centrifuged 300 RCF for 5 min at 4°C. The pellet
(P300) contained cell debris and nuclei while the supernatant
(S300) contained cytoplasm, membranes and mitochondria. S300
then was further centrifuged for 5 min at 13,000 RCF, the pellet
(P13,000) contained the mitochondria and the supernatant
(S13,000) contained the cytoplasm and the membrane fraction.
S13,000 then was centrifuged for another 1 h at 100,000 RCF in an
ultracentrifuge. After recovering the supernatant (S100K-Cytoplas-
mic Fraction), the pellet (P100K-membrane fraction) was resus-
pended in 400 µl of Laemmli sample buffer.
Digitonin permeabilization
To obtain cytosolic and membrane fractions, cultured cells and
dissociated cells from mice and human brains were subjected to
subcellular fraction as shown in (Holden & Horton, 2009). In brief,
cells were washed with cold PBS and trypsinized for 5’, collected
and pellets were obtained after centrifugation at 100 RCF for 5’.
Pellets were washed twice with PBS and then resuspended in Buffer
1 (see below). After 10’ in gently rotation at 4°C, tubes were subject
to centrifugation at 2000 RCF at 4°C for 5’ and supernatants were
harvested (Fraction 1- cytosol). The obtained pellets were then
resuspended in Buffer 2 and incubated 30’ on ice. After 10’ centrifu-
gation at 7500 RCF at 4°C, supernatants were harvested (Fraction 2-
membranes). Buffer 1 (cytosol)—50 mM HEPES pH 7.4, 150 mM
NaCl, 10 μg/ml digitonin (add fresh). Buffer 2 (membranes)—
50 mM HEPES pH 7.4, 150 mM NaCl, 1% NP40.
Mass spectrometry analysis
Protein digestion: After protein precipitation with acetone, pellet was
denatured with 8 M urea in 0.1 M Tris–HCl pH 8.5, reduced at 50°C
with 5 mM TCEP for 30 min and alkylated with 10 mM iodoac-
etamide for 30 min in the dark. First digestion was performed with
5 µg endoproteinase Lys-C (Wako) urea for 6h, followed by a 4
times dilution in Tris buffer and an overnight trypsin digestion
(Promega) at a ratio 1/100. Digestion was stopped with formic acid
(1% final), and peptides were desalted on Sep Pak C18 cartridge
(Waters Corporation). Peptides dissolved in 0.1% TFA were quanti-
fied using colorimetric assay (Pierce – Thermo Fisher Scientific) and
adjusted at 5 mg/ml. N-glycopeptide enrichment: N-glycopeptide
enrichment is based on a protocol previously described (Yakkioui Y
et al, 2017). Peptides (500 µg in 0.1 M sodium acetate pH 5.5,
150 mM NaCl) were incubated with NaIO4 for 1 h then 15 min with
NaS2O3 and mixed with 100 µl AffiGel Hz Hydrazide Gel (Biorad)
overnight. The unbound material was washed with tris 0.1 M pH
8.5, glycine 0.1 M, isopropanol 10% then 3 times with PBS. Lastly,
PNGase F was added for 6h at 37°C and the deglycosylated peptides
were extracted with 0.5% TFA. LC-MS analysis: Total fraction (i.e.,
not Nglyco enriched) and glyco-fraction were analyzed with an
Orbitrap ELITE coupled with a nanoLC chromatographic system
(Thermo Fisher Scientific). Briefly, peptides were separated on a
C18 nano-column with a linear gradient of acetonitrile and analyzed
with a Top 20 CID method. Each sample was analyzed in triplicate.
Data were processed by database searching against Human Uniprot
Proteome database using Proteome Discoverer 2.3 software
(Thermo Fisher Scientific). Precursor and fragment mass tolerance
were set at 10 ppm and 0.6 Da, respectively. Trypsin with up to 2
missed cleavages was set as enzyme. Oxidation (M, +15.995 Da)
and Deamidation (N, +0.984) were set as variable modification and
carbamidomethylation (C, + 57.021) as fixed modification. Peptides
and proteins were filtered with false discovery rate < 1%. N-
glycopeptides were filtered based on the detection of deamidation
and the presence of the consensus motif NxS/T. Lastly, quantitative
values obtained from extracted-ion chromatogram (EIC) were
exported in Perseus for statistical analysis.
Immunoelectron microscopy
Cell cultures were fixed in a 2.5% PFA, 0.05% glutaraldehyde solu-
tion in 80 mM Sorensen phosphate buffer pH 7.4 for 1 h at 4°C and
were scraped and washed 15 min with 0.1 M phosphate buffer. To
facilitate handling of the cells, they were coated with 1.5% agarose
and then cut into 1mm3 pieces. Cells were dehydrated in ethanol
(30–100%) on ice and gradually infiltrated with ethanol/LR White
resin (Delta microscopies) (2/1; 1/1; 1/2; successively) and finally
infiltrated with pure resin overnight at 0°C. Polymerization was
carried out at 60°C for 24h. Thin sections (80 nm) were collected
onto 300 mesh nickel grids and processed for immunochemistry.
Sections were blocked in 20mM Tris–HCl pH 7.6, 150mM NaCl (TBS
buffer), containing 1% BSA, 0.1% BSA-c™ (Aurion), 10% goat
serum (Aurion), 0.2% Tween 20, twice 20 min. Grids were
then incubated for 2h at room temperature with anti-PDIA3 rabbit
antibody (dilution 1:25) in Ab-buffer (TBS pH 7.6, 1% BSA, 0.1%
BSA-c™, 1% goat serum, 0.2% Tween 20). Following four washes
with the Ab-buffer, grids were incubated for 1 h with goat antirabbit
Ig conjugated to 10 nm colloidal gold (1:40 dilution) in Ab-buffer.
Sections were washed in Ab-buffer, fixed in 2.5% glutaraldehyde
and finally stained with 5% uranyl acetate and lead citrate. Negative
controls were carried out, omitting primary antibodies. Sections
were examined on a Tecnai Sphera operating at 200 kV (FEI, Eind-
hoven, Netherlands), and images were recorded with a 4x4 k CCD
Ultrascan camera (Gatan, Pleasanton, USA). We used at least 8
images (x 14,500) displaying both ER and cytoplasm for each condi-
tion. The distribution of PDIA3 was estimated by calculating the
ratio between the particle in the ER and the rest of the cytoplasm.
Mouse work
Tumor cell orthotopic Implantation—Tumor cells (GL261) were
implanted in the brain of immunocompetent C57BL/6rJ, 8-week-old
male mice (Janvier, Laval, France) and tumor cells (U87) were
implanted in the brain of immunodeficient mice NSG (NOD. Cg-
Prkdcscid Il2rgtm1Wjl/SzJ). Mice were purchased from Charles River
Laboratories (Wilmington, MA), 8-week-old male mice (Janvier,
Laval, France). All animal procedures met the European Community
Directive guidelines (Agreement B35-238-40 Biosit Rennes, France/
No DIR 13480) and were approved by the local ethics committee
and ensuring the breeding and the daily monitoring of the animals
in the best conditions of well-being according to the law and the rule
of 3R (Reduce–Refine–Replace). GL261-Luc cells were implanted in
the mouse brain by intracerebral injection followed by tumor
growth analysis using bioluminescence. The mice were anesthetized
intraperitoneally and then fixed on a stereotactic frame. After incis-
ing the scalp, the stereotaxic coordinates were calculated for
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injection of tumor cells into a specific point of the brain, and
reproducible for all the mice used. In the study, the tumor cells,
2,5.104 cells per mice in 1 μL for GL261-luc and 5x104 cells per mice
in 1 μL for U87, are injected at 2.2 mm to the left of the Bregma
and 3.2 mm deep to perform the implantation at the level of
the striatum.
Sulforhodamine-B (SRB) assay
This assay is adapted from (Houghton et al, 2007). In brief,
1X104cells/well were seeded into 96-well plate and incubated over-
night. Next morning, the media were replaced by new media with
different concentrations of Tm, Tg and BFA in the presence or
absence of Etoposide and incubated for 24 and 48 h. At the end of
each time point, cold trichloroacetic acid (TCA) acid was added to
each well at a final concentration of 10% (w/v) and incubated for
1 h at 4°C. Supernatant was then discarded, and each well was
washed with 100µl of distilled water for 5 times and lefted to air-dry
at room temperature. Staining was performed by adding 50 µl of
0.4% SRB (w/v) in 1% acetic acid and plates were then incubated
for 30 min at room temperature. Unbound dye was washed out with
100 µl of 1% acetic acid for 5 times and air-dried. To solubilize
bound SRB dyes, 100 µl of 10mM Tris base (pH 10) was added and
the plate was shaken at 500 rpm for 5 min. absorbance were
measured immediately at 490nm.
Proteinase K protection assay
Pellets obtained after the digitonin treatment (Digitonin permeabi-
lization protocol) or after the 100,000 RCF centrifugation (Differen-
tial centrifugation protocol) were suspended well in 200μl of
homogenization buffer (10 mM HEPES-KOH (pH 7.5), 0.25 M
sucrose). Proteinase-K at a final concentration of 100 μg/ml was
added to the pellets with or without 1% TritonX-100 on ice for
30 min. At the end of the incubation time, proteins were precipi-
tated with 10% trichloroacetic acid on ice for 30 min, and centri-
fuged at 12,000 RCF for 10 min at 4°C. Pellets were washed 3 times
with ice cold acetone and dried. Then, pellets were resuspended in
100 μl of 3 M urea in 1X Laemmli sample buffer.
ENDOH assay
Five volumes of proteins obtained from the digitonin fraction (cy-
tosolic fraction) were mixed with 1 volume of 6X Laemmli buffer
and boiled for 5 min. Then, sodium citrate (pH 5.5) was added to a
final concentration of 67mM and samples were deglycosylated by
adding 250 units of endoglycosidase- H (NEB) for 1 h at 37°C.
Data availability
The mass spectrometry proteomics data have been deposited to
the ProteomeXchange Consortium via the PRIDE partner repository
with the dataset identifier PXD023567 (http://www.ebi.ac.uk/pride/
archive/projects/PXD023567). The dataset is available at: http://
www.ebi.ac.uk/pride.
Expanded View for this article is available online.
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